HFS
RVMD icon

Hughes Financial Services’s Revolution Medicines RVMD Stock Holding History

Hughes Financial Services’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Buy
11
+9
+450% +$1.31K ﹤0.01% 756
2026
Q1 		$195 Buy
+2
New +$202 ﹤0.01% 1105
2025
Q2 		– Sell
-13
Closed -$437 – 1202
2025
Q1 		$437 Buy
+13
New +$528 ﹤0.01% 992

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Hughes Financial Services's RVMD Position: Q2 2026 in Review

Hughes Financial Services increased its Revolution Medicines (RVMD) stake by 450% in Q2 2026, buying an estimated $1.31K and bringing the position to 11 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #756.

Hughes Financial Services first reported a position in RVMD in Q1 2025 and has held it in 3 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Hughes Financial Services held 11 shares of Revolution Medicines worth $2.06K as of Q2 2026.
  • Hughes Financial Services bought 9 Revolution Medicines shares in Q2 2026, an estimated $1.31K.
  • Revolution Medicines made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #756 holding.
  • Hughes Financial Services first reported a position in Revolution Medicines in Q1 2025 and has held it in 3 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.